tiprankstipranks
Trending News
More News >

Allergy Therapeutics Announces Share Transactions and Voting Rights Update

Story Highlights
Allergy Therapeutics Announces Share Transactions and Voting Rights Update

Confident Investing Starts Here:

Allergy Therapeutics ( (GB:AGY) ) has provided an update.

Allergy Therapeutics has issued 13 new ordinary shares to finance the purchase and cancellation of 9,848,333 deferred shares, in line with shareholder-approved repurchase terms. This move has not affected the company’s ordinary shares in issue or the total voting rights, which remain at 4,766,439,951.

More about Allergy Therapeutics

Allergy Therapeutics is a fully integrated commercial biotechnology company specializing in allergy vaccines, focusing on developing treatments to address common allergies.

YTD Price Performance: 18.46%

Average Trading Volume: 523,094

Technical Sentiment Consensus Rating: Sell

Current Market Cap: £367.1M

See more data about AGY stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1